Bristol Myers Squibb (CELG-RI) Interest & Investment Income (2009 - 2013)

Bristol Myers Squibb (CELG-RI) reported Interest & Investment Income of $25.0 million for Q1 2013, down 30.56% year-over-year from $36.0 million in Q1 2012, and down 30.56% quarter-over-quarter from $36.0 million in Q1 2012.

Bristol Myers Squibb (CELG-RI) Interest & Investment Income (2009 - 2013) Analysis & Trends

Bristol Myers Squibb (CELG-RI) has 3 years of Interest & Investment Income data on file, last reported at $25.0 million in Q1 2013.

  • Interest & Investment Income for Q1 2013 came in at $25.0 million, down 30.56% year-over-year; the trailing twelve-month figure through Dec 2009 was $220.0 million (changed N/A YoY), and the FY2012 annual result was $106.0 million, up 16.48% from the prior year.
  • Interest & Investment Income declined to $25.0 million in Q1 2013 per CELG-RI's latest filing, from $36.0 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $220.0 million in Q4 2009 and troughed at $25.0 million in Q1 2013.
  • A 3-year average of $93.7 million and a median of $36.0 million in 2012 frame the typical range for Interest & Investment Income.
  • On a YoY basis, Interest & Investment Income climbed as much as 30.56% in 2013 and fell as far as 30.56% in 2013.
  • A 3-year view of Interest & Investment Income shows it stood at $220.0 million in 2009, then tumbled by 83.64% to $36.0 million in 2012, then sank by 30.56% to $25.0 million in 2013.
  • Business Quant data shows CELG-RI's Interest & Investment Income at $25.0 million in Q1 2013, $36.0 million in Q1 2012, and $220.0 million in Q4 2009.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 29.66 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 229.00 Mn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -645.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Bristol Myers Squibb - - 8.07 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2013 25.00 Mn
Mar 31, 2012 36.00 Mn
Dec 31, 2009 220.00 Mn